Hydrocodone Polistirex and Chlorpheniramine Polistirex

Neos Therapeutics LP🇺🇸 United States

FDA Page

Effective Date: Jun 2, 2022
Approval ID: 0a442026-486d-105a-e054-00144ff88e88
Products: 1 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension safely and effectively. See full prescribing information for Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension. Hydrocodone polistirex and chlorpheniramine polistirex extended-release suspension, for oral administration, CII Initial U.S. Approval: 1987

Quick Stats

Total Products1

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.